The Role of Gut Microbiota in the Modulation of Pulmonary Immune Response to Viral Infection Through the Gut-Lung Axis
Authors:
Top Cited Papers
Open Access
- 1 August 2025
- journal article
- review article
- Published by Taylor & Francis in Journal of Inflammation Research
- Vol. ume 18, 11755-11781
Abstract
Viral respiratory infections, including influenza, respiratory syncytial virus (RSV), and SARS-CoV-2, remain major global health challenges due to their high morbidity and mortality. Emerging evidence highlights the pivotal role of the gut-lung axis in regulating pulmonary immunity. The gut microbiota communicates with the lungs via endocrine, immune, and neuroimmune pathways—particularly through metabolites such as short-chain fatty acids (SCFAs) and vagus nerve-mediated signaling—which modulate immune cells including alveolar macrophages and dendritic cells. Disruption of gut microbial balance has been linked to impaired pulmonary immune responses and increased susceptibility to infection. This review synthesizes findings from animal models and clinical studies, demonstrating that interventions such as probiotics (eg, Lactobacillus gasseri), prebiotics (eg, galacto-oligosaccharides), fecal microbiota transplantation (FMT), and Traditional Chinese Medicine (eg, Astragalus, curcumin) can enhance antiviral cytokine production, restore gut-lung homeostasis, and reduce lung inflammation. For example, FMT from H7N9-survivor mice improved influenza resistance in recipients, and oral probiotics reduced respiratory failure risk in COVID-19 patients. These findings suggest that gut-lung axis modulation is a promising adjunctive approach for treating viral respiratory infections. Future research should prioritize personalized microbiome-based therapies and large-scale clinical trials to validate efficacy and safety.Keywords
This publication has 175 references indexed in Scilit:
- Severity of Respiratory Syncytial Virus vs COVID-19 and Influenza Among Hospitalized US AdultsJAMA Network Open, 2024
- Efficacy of Ivermectin Treatment on Disease Progression Among Adults With Mild to Moderate COVID-19 and ComorbiditiesJAMA Internal Medicine, 2022
- The lung microbiota: role in maintaining pulmonary immune homeostasis and its implications in cancer development and therapyCellular and Molecular Life Sciences, 2020
- The human rhinovirus: human‐pathological impact, mechanisms of antirhinoviral agents, and strategies for their discoveryMedicinal Research Reviews, 2010
- Viral respiratory infections in hospitalized and community control children in AlaskaJournal of Medical Virology, 2010
- Dietary fructooligosaccharides and potential benefits on healthJournal of Physiology and Biochemistry, 2009
- Adenovirus receptors: implications for tropism, treatment and targetingReviews in Medical Virology, 2009
- Chemokines and chemokine receptors in mucosal homeostasis at the intestinal epithelial barrier in inflammatory bowel diseaseInflammatory Bowel Diseases, 2008
- Dendritic Cells: Translating Innate to Adaptive Immunity2006
- Effectiveness of Oseltamivir in Preventing Influenza in Household ContactsA Randomized Controlled TrialJAMA, 2001